Cardihab CEO Helen Souris Appointed to the MTAA Board
Cardihab is proud to celebrate the appointment of our CEO, Helen Souris, to the Medical Technology Association of Australia (MTAA) Board of Directors. Helen joins a group of exceptional leaders from across the medtech industry who will help shape the strategic direction of the sector at a pivotal time for innovation in healthcare. We extend our congratulations to other newly appointed Directors:
- Ofer Elboher GAICD, Abbott
- Paul Petherbridge, LifeHealthcare
- Sarah Najdek, Johnson & Johnson MedTech
- Brendan Cummins, Baxter International Inc.
The new Board members represent a diverse mix of expertise and perspectives across medical devices, diagnostics, and digital health, reflecting the evolving role technology plays in improving patient outcomes and system efficiency.
Helen said:
“It’s a privilege to join the MTAA Board. I’m passionate about representing the growing community of digital therapeutics and digital health organisations - particularly small to medium enterprises that are driving real-world change through innovation, collaboration and patient-centred design.”
Helen’s appointment reflects Cardihab’s ongoing commitment to supporting the growth of the digital health sector through evidence-based innovation that improves accessibility and outcomes for patients living with chronic diseases, and delivers productivity and efficiency gains for clinicians and the healthcare system.
We also extend our congratulations to the continuing Board members
- Chair Liz Carnabuci, Medtronic
- Vice Chair Warren Bingham, MedTech International
- Warren Ballinger, Zimmer Biomet ANZ
- Chelsea Cornelius, Stratos MedTech Pty Ltd
- James Doyle, Stryker
- Jack Lancaster, Evolution Surgical
- Mick Trevaskis (GAICD), Device Technologies
We look forward to contributing to the MTAA’s mission of championing medical technology for a healthier Australia, and supporting Ian Burgess and his team at MTAA, in fostering a thriving, impactful, and innovative medtech ecosystem.